Pre-workout Supplement Versus Caffeine on Energy Expenditure.

NCT ID: NCT04539054

Last Updated: 2020-09-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-01

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of this study was to examine the acute effects of a multi-ingredient pre-workout supplement versus an ergogenic dose of caffeine (6 mg/kg) on energy expenditure during low-intensity exercise. The effects of these substances on substrate utilization, gas exchange, and psychological factors were also investigated. Twelve males (mean ± SD: age = 22.8 ± 2.4 years) completed three bouts of 60-min of treadmill exercise at 4.8-6.4 km/hr on separate days after consuming a pre-workout supplement, 6 mg/kg of caffeine, or placebo in a randomized fashion. The pre-workout and caffeine supplements resulted in significantly greater energy expenditure (p \< 0.001, p = 0.006, respectively), VO2 (p \< 0.001, p = 0.007, respectively), VCO2 (p = 0.006, p = 0.049, respectively), and VE (p \< 0.001, p = 0.007, respectively), but not rates of fat or carbohydrate oxidation or respiratory exchange ratio compared to placebo (collapsed across condition). In addition, the pre-workout supplement increased feelings of alertness (p = 0.015) and focus (p = 0.005) 30-minutes post-ingestion and decreased feelings of fatigue (p = 0.014) during exercise compared to placebo (collapsed across condition). Thus, the pre-workout supplement increased energy expenditure and measures of gas exchange to the same extent as 6 mg/kg of caffeine with concomitant increased feelings of alertness and focus and decreased feelings of fatigue.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pre-Workout Condition

This condition consisted of the ingestion of one serving of the pre-workout supplement.

Group Type EXPERIMENTAL

ENGN Shred

Intervention Type DIETARY_SUPPLEMENT

ENGN Shred is a multi-ingredient pre-workout supplement.

Caffeine Condition

This condition consisted of the ingestion of 6 mg of caffeine per kg of body mass.

Group Type EXPERIMENTAL

Nutricost caffeine powder

Intervention Type DIETARY_SUPPLEMENT

Caffeine powder.

Placebo condition

This condition consisted of the ingestion of a placebo.

Group Type PLACEBO_COMPARATOR

Crystal Light

Intervention Type DIETARY_SUPPLEMENT

Non-caloric Crystal Light matched for the pre-workout in terms of flavor and consistency.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ENGN Shred

ENGN Shred is a multi-ingredient pre-workout supplement.

Intervention Type DIETARY_SUPPLEMENT

Nutricost caffeine powder

Caffeine powder.

Intervention Type DIETARY_SUPPLEMENT

Crystal Light

Non-caloric Crystal Light matched for the pre-workout in terms of flavor and consistency.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male

Exclusion Criteria

* history of medical or surgical events, including cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders;
* use of any medications
* use of nutritional supplements
* habitual use of caffeine (≥1 caffeinated beverage per day)
* participation in another clinical trial or investigation of another investigational product within 30 days prior to screening/enrollment.
Minimum Eligible Age

19 Years

Maximum Eligible Age

29 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northern Illinois University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Clayton Camic

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clayton L Camic, PhD

Role: PRINCIPAL_INVESTIGATOR

Northern Illinois University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Exercise Physiology Laboratory

DeKalb, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HS19-0163

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Caffeine and Training Intensity Quantification
NCT06210984 NOT_YET_RECRUITING NA